More than $37 million of renewed National Institute’s of Health funding is flowing into four major research centers in the University of Texas System, along with Rice University, as they partner to expand clinical and translational research targeting superior outcomes for those not only in Texas but across the United States.
The federal government infused Texas with a five-year federal grant building upon the formative work of the Center for Clinical and Translational Sciences, which the University of Texas Health Science Center at Houston (UTHealth) and the University of Texas MD Anderson Cancer Center first established in 2006 with one of the NIH’s inaugural Clinical and Translational Science Awards.
A major Research Complex in Texas
The funds are flowing into additional research sites, such as the University of Texas Rio Grande Valley, the University of Texas Health Science Center at Tyler and Rice University. Hence, the research region extends from Houston up through East Texas and down through the Rio Grande Valley.
Clinical Research as a Care Option: The Underrepresented
Hitting a recurring theme across the United States, clinical trial research dollars now flow toward the underrepresented minorities—African Americans, Latinos and others marginalized such as LGBTQ, not to mention children and families in lower socioeconomic scenarios and people and communities struggling with opioid addiction.
Follow the source for quotes from key leaders from various Texas research centers. It is an exciting time in Texas as federal dollars will flow to those in real need of healthcare assistance.